electroCore, Inc. (ECOR) earnings
ECOR earnings moved a median of -4.90% by the close. Quarterly and annual ECOR reports and results, each read against the price at its own news timestamp. Back to the ECOR overview →
19 measured ECOR earnings events.
Where these ECOR earnings landedvs 19 measured ECOR earnings reactions
| Middle 50% of ECOR earnings reactions | -8.44% to +6.91% |
|---|---|
| Median reaction (to close) | -4.90% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 ECOR earnings events with a measured close landed between -8.44% and +6.91%; 26% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| electroCore Announces Second Quarter 2026 Financial Results | Press release | -0.82% | +20.75% | |
| electroCore Announces First Quarter 2026 Financial Results | Press release | -3.19% | -4.78% | |
| Form 10-K electroCore, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.62% | -2.50% | |
| electroCore Announces Third Quarter 2025 Financial Results | Press release | -2.67% | +17.50% | |
| Form 10-Q electroCore, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.67% | +17.50% | |
| electroCore Announces Second Quarter 2025 Financial Results | Press release | -2.01% | -14.01% | |
| Form 10-Q electroCore, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.01% | -14.01% | |
| electroCore Announces First Quarter 2025 Financial Results | Press release | -4.24% | -10.21% | |
| Form 10-Q electroCore, Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.24% | -10.21% | |
| Form 10-K electroCore, Inc. For: Dec 31 | SEC filing · Form 10-K | -10.71% | -18.59% | |
| electroCore Announces Third Quarter 2024 Financial Results | Press release | -2.98% | +15.74% | |
| Form 10-Q electroCore, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.98% | +15.74% | |
| electroCore Announces Second Quarter 2024 Financial Results | Press release | -0.48% | -4.90% | |
| Form 10-Q electroCore, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.48% | -4.90% | |
| electroCore Announces First Quarter 2024 Financial Results | Press release | -2.06% | -6.68% | |
| Form 10-Q electroCore, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.06% | -6.68% | |
| Form 10-K electroCore, Inc. For: Dec 31 | SEC filing · Form 10-K | +4.35% | -1.93% | |
| electroCore Announces Third Quarter 2023 Financial Results | Press release | -4.44% | -6.03% | |
| Form 10-Q electroCore, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.44% | -6.03% |
Keep exploring
More ECOR: analyst actions → · SEC filings → · ECOR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Avadel Pharmaceuticals plc - Ordinary Share (AVDL) | 246 | -0.16% | 42% |
| Cumberland Pharmaceuticals Inc. (CPIX) | 245 | 0.00% | 49% |
| Oragenics Inc. (OGEN) | 245 | -0.79% | 33% |
| Universal Health Services, Inc. (UHS) | 245 | -0.04% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.